Cited by 651Amyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration MechanismsSpinal Cord Injury Research

The DOI matches its Crossref record; 130 of the 133 references it cites were found in a registry or an index.

Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease

Open access

Philips, Thomas, Robberecht, Wim·2011·The Lancet Neurology

DOI 10.1016/s1474-4422(11)70015-1

Open this paper in CoChat — free account

Abstract

Neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS) are characterised by the appearance of reactive microglial and astroglial cells, a process referred to as neuroinflammation. In transgenic mouse models of mutant SOD1-associated familial ALS, reactive microglial cells and astrocytes actively contribute to the death of motor neurons. The biological processes that drive this glial reaction are complex and have both beneficial and deleterious effects on motor neurons. Therapeutic interventions targeting these cells are being explored. An improved understanding of the biological processes that cause neuroinflammation will help to define its medical importance and to identify the therapeutic potential of interfering with this reaction.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(11)70015-1

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341

Show all 133 references

Sorted by citations

Items 401–500 of 651

Relationship between Liver Pathology and Disease Progression in a Murine Model of Amyotrophic Lateral Sclerosis
Lee, S. H., & Yang, E. J. (2018) · Neurodegenerative Diseases · doi:10.1159/000491392 · Cited by 15
Retinal Ganglion Cell Loss and Microglial Activation in a SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Rojas, P., Ramirez, A. I., Cadena, M., Fernández‐Albarral, J. A., Salobrar‐García, E., López‐Cuenca, I., Santos‐García, I., de Lago, E., Urcelay-Segura, J. L., Ramirez, J. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041663 · Cited by 17
Dual Role of Lysophosphatidic Acid Receptor 2 (LPA2) in Amyotrophic Lateral Sclerosis
Puigdomenech, M., Martínez‐Muriana, A., Andrés‐Benito, P., Ferrer, I., Chun, J. J. M., & López‐Vales, R. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.600872 · Cited by 16
Can Transcriptomics Cut the Gordian Knot of Amyotrophic Lateral Sclerosis?
Henriques, A., & de Aguilar, J. G. (2011) · Current Genomics · doi:10.2174/138920211797904043 · Cited by 15
KATP Channel Expression and Genetic Polymorphisms Associated with Progression and Survival in Amyotrophic Lateral Sclerosis
Vidal-Taboada, J. M., Pugliese, M., Salvadó, M., Gámez, J., Mahy, N., & Rodríguez, M. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0970-7 · Cited by 15
Emerging Ferroptosis Involvement in Amyotrophic Lateral Sclerosis Pathogenesis: Neuroprotective Activity of Polyphenols
Russo, A., Putaggio, S., Tellone, E., Calderaro, A., Cirmi, S., Laganà, G., Ficarra, S., Barreca, D., & Patanè, G. T. (2025) · Molecules · doi:10.3390/molecules30061211 · Cited by 18
Pathophysiology of Amyotrophic Lateral Sclerosis
Fabian, H., Clara, M., & Alvaro, G. (2013) · InTech eBooks · doi:10.5772/56562 · Cited by 17
Licochalcone A Inhibits Prostaglandin E2 by Targeting the MAPK Pathway in LPS Activated Primary Microglia
Bhatia, H. S., Apweiler, M., Sun, L., Baron, J., Tirkey, A., & Fiebich, B. L. (2023) · Molecules · doi:10.3390/molecules28041927 · Cited by 14
Desloratadine alleviates ALS-like pathology in hSOD1G93A mice via targeting 5HTR2A on activated spinal astrocytes
Lu, J., He, A.-X., Jin, Z.-Y., Zhang, M., Li, Z., Zhou, F., Ma, L., Jin, H.-M., Wang, J., & Shen, X. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01223-2 · Cited by 14
Amyotrophic lateral sclerosis in pregnancy is associated with a vascular endothelial growth factor promoter genotype
Lunetta, C., Sansone, V., Penco, S., Mosca, L., Tarlarini, C., Avemaria, F., Maestri, E., Melazzini, M. G., Meola, G., & Corbo, M. (2014) · European Journal of Neurology · doi:10.1111/ene.12345 · Cited by 14
TLR2/4 deficiency prevents oxygen-induced vascular degeneration and promotes revascularization by downregulating IL-17 in the retina
He, C., Lai, P., Wang, J., Zhou, T., Huang, Z., Zhou, L., & Liu, X. (2016) · Scientific Reports · doi:10.1038/srep27739 · Cited by 15
Systemic inflammation and subsequent risk of amyotrophic lateral sclerosis: Prospective cohort study
Batty, G. D., Mika Kivimaki, B., Frank, P., Galé, C. R., & Wright, L. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.026 · Cited by 14
Histamine Is an Inducer of the Heat Shock Response in SOD1-G93A Models of ALS
Apolloni, S., Caputi, F., Pignataro, A., Amadio, S., Fabbrizio, P., Ammassari‐Teule, M., & Volonté, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153793 · Cited by 14
Increased cerebrospinal fluid levels of cytokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1β (MIP-1β) in patients with amyotrophic lateral sclerosis
Martínez, H. R., Escamilla-Ocañas, C. E., Camara-Lemarroy, C. R., González‐Garza, M. T., Moreno-Cuevas, J. E., & Sarreón, M. A. G. (2020) · Neurología (English Edition) · doi:10.1016/j.nrleng.2017.07.016 · Cited by 15
A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation
Vallarola, A., Tortarolo, M., Gioia, R. D., Iamele, L., de Jonge, H., de Nola, G., Bovio, E., Pasetto, L., Bonetto, V., Freschi, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228542 · Cited by 16
Expression and Cell Type-specific Localization of Inflammasome Sensors in the Spinal Cord of SOD1(G93A) Mice and Sporadic Amyotrophic lateral sclerosis Patients
Hummel, C., Leylamian, O., Pösch, A., Weis, J., Aronica, E., Beyer, C., & Johann, S. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.03.023 · Cited by 15
Astrocytic TGF-β1: detrimental factor in ALS
Endo, F., & Yamanaka, K. (2015) · Oncotarget · doi:10.18632/oncotarget.4786 · Cited by 14
Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient
Lamas, N. J., & Roybon, L. (2021) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2021.773424 · Cited by 12
NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons
Killoy, K. M., Harlan, B. A., Pehar, M., & Vargas, M. R. (2022) · The FASEB Journal · doi:10.1096/fj.202101275r · Cited by 12
Monocyte Chemoattractant Protein-1 upregulates GABA-induced current: Evidence of modified GABAA subunit composition in cortical neurons from the G93A mouse model of Amyotrophic Lateral Sclerosis
Caioli, S., Pieri, M., Antonini, A., Guglielmotti, A., Severini, C., & Zona, C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.045 · Cited by 14
Is amyotrophic lateral sclerosis a primary astrocytic disease?
Sica, R. E. P. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.08.036 · Cited by 13
A Possible Role for Platelet-Activating Factor Receptor in Amyotrophic Lateral Sclerosis Treatment
Briones, M. R. S., Snyder, A. M., Ferreira, R. C., Neely, E. B., Connor, J. R., & Broach, J. R. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00039 · Cited by 13
Combined intramuscular and intraspinal transplant of bone marrow cells improves neuromuscular function in the SOD1G93A mice
Martínez‐Muriana, A., Pastor, D., Mancuso, R., Rando, A., Osta, R., Martı́nez, S., López‐Vales, R., & Navarro, X. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-1573-6 · Cited by 13
BMP/TGF‐β signaling as a modulator of neurodegeneration in ALS
Russo, K., & Wharton, K. A. (2021) · Developmental Dynamics · doi:10.1002/dvdy.333 · Cited by 13
Oxidative stress induced by cumene hydroperoxide produces synaptic depression and transient hyperexcitability in rat primary motor cortex neurons
Pardillo-Díaz, R., Carrascal, L., Barrionuevo, G., & Nunez‐Abades, P. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.06.002 · Cited by 13
Riluzole Exhibits No Therapeutic Efficacy on a Transgenic Rat model of Amyotrophic Lateral Sclerosis
Chen, S., Liao, Q., Lu, K., Zhou, J., Huang, C., & Bi, F. (2020) · Current Neurovascular Research · doi:10.2174/1567202617666200409125227 · Cited by 12
A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model
Post, J., Kogel, V., Schaffrath, A., Lohmann, P., Shah, N. J., Langen, K., Willbold, D., Willuweit, A., & Kutzsche, J. (2021) · Molecules · doi:10.3390/molecules26061590 · Cited by 12
Perturbations of the Proteome and of Secreted Metabolites in Primary Astrocytes from the hSOD1(G93A) ALS Mouse Model
Stella, R., Bonadio, R. S., Cagnin, S., Massimino, M. L., Bertoli, A., & Peggion, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137028 · Cited by 12
CSF concentrations of adipsin and adiponectin in patients with amyotrophic lateral sclerosis
Martínez, H. R., Escamilla-Ocañas, C. E., Camara-Lemarroy, C. R., González‐Garza, M. T., Tenorio-Pedraza, J. M., & Hernández-Torre, M. (2017) · Acta Neurologica Belgica · doi:10.1007/s13760-017-0798-3 · Cited by 12
GLT1 gene delivery based on bone marrow-derived cells ameliorates motor function and survival in a mouse model of ALS
Ohashi, N., Terashima, T., Katagi, M., Nakae, Y., Okano, J., Suzuki, Y., & Kojima, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-92285-x · Cited by 13
Beyond Antioxidants: The Emerging Role of Nrf2 Activation in Amyotrophic Lateral Sclerosis (ALS)
Sharbafshaaer, M., Pepe, R., Notariale, R., Canale, F., Tedeschi, G., Tessitore, A., Bergamo, P., & Trojsi, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209872 · Cited by 15
Aberrant protein aggregation in amyotrophic lateral sclerosis
Wang, H., & Zeng, R. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12485-z · Cited by 11
Computational Strategies to Identify New Drug Candidates against Neuroinflammation
Pavan, M., Bassani, D., Bolcato, G., Bissaro, M., Sturlese, M., & Moro, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220208095122 · Cited by 11
Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis
Brewer, M. K., Torres, P., Ayala, V., Portero‐Otín, M., Pamplona, R., Andrés‐Benito, P., Ferrer, I., Gentry, M. S., Guinovart, J. J., & Durán, J. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15906 · Cited by 11
Fingolimod Suppresses the Proinflammatory Status of Interferon-γ-Activated Cultured Rat Astrocytes
Bobnar, S. T., Stenovec, M., Miš, K., Pirkmajer, S., & Zorec, R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1481-x · Cited by 11
Regional differences in the inflammatory and heat shock response in glia: implications for ALS
Clarke, B. E., Gil, R. S., Yip, J., Kalmár, B., & Greensmith, L. (2019) · Cell Stress and Chaperones · doi:10.1007/s12192-019-01005-y · Cited by 11
Glial-restricted precursors as potential candidates for ALS cell-replacement therapy
Kruminis-Kaszkiel, E., Wojtkiewicz, J., & Maksymowicz, W. (2014) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2014-1989 · Cited by 11
Central Nervous System-Peripheral Immune System Dialogue in Neurological Disorders: Possible Application of Neuroimmunology in Urology
Park, H., Park, M.-J., & Kwon, M. (2016) · International Neurourology Journal · doi:10.5213/inj.1632614.307 · Cited by 11
Inflammatory cytokines disrupt astrocyte exosomal HepaCAM-mediated protection against neuronal excitotoxicity in the SOD1G93A ALS model
Jin, S., Tian, Y., Hacker, J., Chen, X., Bertolio, M., Reynolds, C. R., Jarvis, R., Hu, J., Promes, V., Halim, D. O., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq3350 · Cited by 10
Adverse events reporting of edaravone: a real-world analysis from FAERS database
Shang, Q., Zhou, J., Ye, J., & Chen, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-92605-5 · Cited by 10
SOD1G93A transgenic mouse CD4+ T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment
Mesnard, N. A., Xin, J., Haulcomb, M. M., Batka, R. J., Sanders, V. M., & Jones, K. J. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.019 · Cited by 10
Dietary Fiber and Amyotrophic Lateral Sclerosis: Results From 5 Large Cohort Studies
Fondell, E., O’Reilly, É. J., Fitzgerald, K. C., Falcone, G. J., Kolonel, L. N., Park, Y., McCullough, M. L., & Ascherio, A. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu089 · Cited by 11
Astrocyte–Neuron Communications
McIver, S. R., Faideau, M., & Haydon, P. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_2 · Cited by 12
Molecular Mechanisms of Amyotrophic Lateral Sclerosis
Collins, M. A., & Bowser, R. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802257-3.00004-3 · Cited by 10
Omega-3 Hastens and Omega-6 Delays the Progression of Neuropathology in a Murine Model of Familial ALS
Boumil, E. F., Vohnoutka, R. B., Liu, Y., Lee, S., & SHEA, T. B. (2017) · The Open Neurology Journal · doi:10.2174/1874205x01711010084 · Cited by 10
SOD1/Rag2 Mice with Low Copy Number of SOD1 Gene as a New Long-Living Immunodeficient Model of ALS
Majchrzak, M., Drela, K., Andrzejewska, A., Rogujski, P., Figurska, S., Fiedorowicz, M., Walczak, P., Janowski, M., Łukomska, B., & Stanaszek, L. (2019) · Scientific Reports · doi:10.1038/s41598-018-37235-w · Cited by 10
Loss of CREST leads to neuroinflammatory responses and ALS-like motor defects in mice
Cheng, C., Yang, K., Wu, X., Zhang, Y., Shan, S., Gitler, A. D., Ghosh, A., & Qiu, Z. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0152-1 · Cited by 11
NF-κB disinhibition contributes to dendrite defects in fly models of neurodegenerative diseases
Han, M., Kwon, M. J., Ko, B. S., Hyeon, D. Y., Lee, D., Kim, H., Hwang, D., & Lee, S. B. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.202004107 · Cited by 10
A Glycosylated Prodrug to Attenuate Neuroinflammation and Improve Cognitive Deficits in Alzheimer’s Disease Transgenic Mice
Kim, M., Park, M., Nam, G., Lee, M., Kang, J., Song, I., Choi, M., Jin, H. K., Bae, J., & Lim, M. H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00677 · Cited by 10
Early upregulation of cytosolic phospholipase A2α in motor neurons is induced by misfolded SOD1 in a mouse model of amyotrophic lateral sclerosis
Malada-Edelstein, Y. F., Solomonov, Y., Hadad, N., Alfahel, L., Israelson, A., & Lévy, R. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02326-5 · Cited by 10
Dual action of chronic ethanol treatment on LPS-induced response in C6 glioma cells
Loureiro, S. O., Heimfarth, L., de Lima, B. O., Leite, M. C., Guerra, M. C., Gonçalves, C. A., & Pessoa‐Pureur, R. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.04.004 · Cited by 10
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial)
Salamone, P., Fuda, G., Casale, F., Marrali, G., Lunetta, C., Caponnetto, C., Mazzini, L., Bella, V. L., Mandrioli, J., Simone, I. L., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034049 · Cited by 10
Neurodegeneration and the immune system: lessons from autoimmune encephalitis
Campetella, L., Smolik, K., Farina, A., Joubert, B., Muñiz‐Castrillo, S., Desestret, V., & Honnorat, J. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13094-0 · Cited by 12
Recent therapeutic advances in the treatment and management of amyotrophic lateral sclerosis: the era of regenerative medicine
Marchi, F. D., Lombardi, I., Bombaci, A., Diamanti, L., Olivero, M., Perciballi, E., Tornabene, D., Vulcano, E., Ferrari, D., & Mazzini, L. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2508781 · Cited by 9
Molecular hydrogen therapy: A “democratic” emerging strategy against aging and age-related diseases
Brandi, G., Delbaldo, C., Deserti, M., Relli, V., Rimedio, S., Palloni, A., Deiana, C., Saccoccio, G., Ingenito, R., & Tavolari, S. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102802 · Cited by 9
Differential cortical gray matter changes in early- and late-onset patients with amyotrophic lateral sclerosis
Ai, Y., Li, F. Y., Hou, Y., Li, X., Li, W., Qin, K., Suo, X., Lei, D., Shang, H., & Gong, Q. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad426 · Cited by 9
Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytes
Leventoux, N., Morimoto, S., Ishikawa, M., Nakamura, S., Ozawa, F., Kobayashi, R., Watanabe, H., Supakul, S., Okamoto, S., Zhou, Z., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02734-w · Cited by 10
Magnetic resonance imaging of pathological processes in rodent models of amyotrophic lateral sclerosis
Evans, M. C., Modo, M., Talbot, K., Sibson, N., & Turner, M. R. (2011) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2011.623300 · Cited by 9
Assessing neuraxial microstructural changes in a transgenic mouse model of early stage Amyotrophic Lateral Sclerosis by ultra‐high field MRI and diffusion tensor metrics
Gatto, R. G., Weissmann, C., Amin, M., Finkielsztein, A., Sumagin, R., Mareci, T. H., Uchitel, O. D., & Magin, R. L. (2020) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12112 · Cited by 9
Iron-sensitive MR imaging of the primary motor cortex to differentiate hereditary spastic paraplegia from other motor neuron diseases
Cosottini, M., Donatelli, G., Ricca, I., Bianchi, F., Frosini, D., Montano, V., Migaleddu, G., Prete, E. D., Tessa, A., Cecchi, P. C., et al. (2022) · European Radiology · doi:10.1007/s00330-022-08865-6 · Cited by 9
Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks
Willekens, S. M. A., Weehaeghe, D. V., Damme, P. V., & Laere, K. V. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3587-y · Cited by 9
Targeting Purinergic Signaling and Cell Therapy in Cardiovascular and Neurodegenerative Diseases
Andrejew, R., Glaser, T., Oliveira‐Giacomelli, Á., Ribeiro, D. E., de Godoy, M. A., Granato, A. E. C., & Ulrich, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-31206-0_14 · Cited by 10
Putative Roles and Therapeutic Potential of the Chaperone System in Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Noori, L., Saqagandomabadi, V., Felice, V. D., David, S., Bavisotto, C. C., Bucchieri, F., Cappello, F., de Macario, E. C., Macario, A. J. L., & Scalia, F. (2024) · Cells · doi:10.3390/cells13030217 · Cited by 8
Adverse effects of a SOD1-peptide immunotherapy on SOD1G93A mouse slow model of amyotrophic lateral sclerosis
Sábado, J., Casanovas, A., Rodrigo, H. M., Arqué, G., & Esquerda, J. E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.027 · Cited by 8
Neuroinflammation as the Proximate Cause of Signature Pathogenic Pattern Progression in Amyotrophic Lateral Sclerosis, Aids, and Multiple Sclerosis
Agius, L. M. (2012) · Pathology Research International · doi:10.1155/2012/169270 · Cited by 8
Immune-microbiome interplay and its implications in neurodegenerative disorders
Uniyal, A., Tiwari, V., Rani, M., & Tiwari, V. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00807-3 · Cited by 9
Amyotrophic Lateral Sclerosis
Lonergan, R., Mistumoto, H., & Murray, B. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6567-6_20 · Cited by 8
Genetics of Amyotrophic Lateral Sclerosis
Koppers, M., van Es, M. A., van den Berg, L. H., Veldink, J. H., & Pasterkamp, R. J. (2012) · InTech eBooks · doi:10.5772/31304 · Cited by 10
Incremento de las citoquinas proteína quimiotáctica de monocitos-1 (MCP-1) y proteína inflamatoria macrofágica-1β (MIP-1β) en líquido cefalorraquídeo de pacientes con esclerosis lateral amiotrófica
Martínez, H. R., Escamilla-Ocañas, C. E., Camara-Lemarroy, C. R., González‐Garza, M. T., Moreno-Cuevas, J. E., & Sarreón, M. A. G. (2017) · Neurología · doi:10.1016/j.nrl.2017.07.020 · Cited by 8
TRUSS inhibition protects against high fat diet (HFD)-stimulated brain injury by alleviation of inflammatory response
Zhu, Q., Zhu, Y., & Wang, W. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.01.058 · Cited by 8
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis
Meanti, R., Bresciani, E., Rizzi, L., Coco, S., Zambelli, V., Dimitroulas, A., Molteni, L., Omeljaniuk, R. J., Locatelli, V., & Torsello, A. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220915103613 · Cited by 7
Exploring antioxidant strategies in the pathogenesis of ALS
Pinilla-González, V., Montecinos-Barrientos, B., Martin-Kommer, C., Chichiarelli, S., Saso, L., & Rodrigo, R. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0842 · Cited by 8
TMEM119-positive microglia were increased in the brains of patients with amyotrophic lateral sclerosis
Togawa, N., Ayaki, T., Yoshii, D., Maki, T., Sawamoto, N., & Takahashi, R. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137829 · Cited by 7
Association of apolipoprotein E ε4 allele and amyotrophic lateral sclerosis in Chinese population
He, D., Shang, L., Liu, Q. F., Shen, D., Sun, X., Cai, Z., Zhao, X., Liu, L., Yang, X., Liu, M., et al. (2021) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2021.1953077 · Cited by 7
Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3
Haukedal, H., Lorenzen, S. S., Westi, E. W., Corsi, G. I., Gadekar, V. P., McQuade, A., Davtyan, H., Doncheva, N. T., Schmid, B., Chandrasekaran, A., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.024 · Cited by 7
Immune signaling and function in neurodegeneration
Latour, Y. L., & McGavern, D. B. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199850 · Cited by 9
The potential role of dietary intervention for the treatment of neuroinflammation
Holton, K. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85841-0.00022-5 · Cited by 6
PKR modulates sterile systemic inflammation-triggered neuroinflammation and brain glucose metabolism disturbances
Cheng, W., Lee, X.-Z., Lai, M. S., Ho, J. Y. S., & Chang, R. C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1469737 · Cited by 7
Anti‐Inflammatory Effect of Gamisoyo‐San in an Animal Model of Amyotrophic Lateral Sclerosis
Park, S., & Yang, E. J. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/8580152 · Cited by 6
ALSUntangled #67: rituximab
Li, X., Armon, C., Barkhaus, P. E., Barnes, B., Benatar, M. G., Bertorini, T. E., Bromberg, M. B., Carter, G. T., Crayle, J. I., Cudkowicz, M., et al. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2122845 · Cited by 6
Cell-based Research and Therapy for Amyotrophic Lateral Sclerosis: Promises and Challenges
Vasques, J. F., Teixeira‐Pinheiro, L. C., Gonçalves, R. G. D. J., Méndez‐Otero, R., & Gubert, F. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.amyotrophiclateralsclerosis.celltherapy.2021 · Cited by 6
Insights into the pharmaceuticals and mechanisms of neurological orphan diseases: Current Status and future expectations
Ramalho, T. C., de Castro, A. A., Tavares, T. S., Silva, M. D. C., Silva, D. R., Cesar, P. H., Santos, L. D. A., da Cunha, E. F. F., Nepovimová, E., & Kuča, K. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.011 · Cited by 6
Targeted ErbB4 receptor activation ameliorates neuronal deficits via DOCK3 signaling in a transgenic mouse AD model
Liu, C., Zhao, Y., Dao, J.-J., Zhang, W., Liu, J., Ma, Y.-K., Qiao, C.-M., Cui, C., Chen, S., Shen, Y., et al. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00739 · Cited by 5
Neuroinflammation and Oxidative Stress in SOD1 Animal Models of ALS: A Meta-analysis Study of Their Effects on Disease Onset and Progression
Ciuro, M., Sangiorgio, M., Leanza, G., & Gulino, R. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05773-4 · Cited by 5
Insights on Natural Products Against Amyotrophic Lateral Sclerosis (ALS)
Monteiro, K. L. C., Alcântara, M. G. D. S., de Aquino, T. M., & da Silva‐Júnior, E. F. (2023) · Current Neuropharmacology · doi:10.2174/1570159x22666231016153606 · Cited by 7
A Potential Role of Interleukin-5 in the Pathogenesis and Progression of Amyotrophic Lateral Sclerosis: A New Molecular Perspective
Moțățăianu, A., Andone, S. R., Stoian, A., Bălașa, R., Huţanu, A., & Sărmășan, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073782 · Cited by 7
Advantages and Pitfalls in Experimental Models Of ALS
Boido, M., Buschini, E., Piras, A., Spigolon, G., Valsecchi, V., Mazzini, L., & Vercelli, A. (2012) · InTech eBooks · doi:10.5772/31380 · Cited by 5
Identification of B6SJL mSOD1G93A mouse subgroups with different disease progression rates
Haulcomb, M. M., Mesnard, N. A., Batka, R. J., Meadows, R. M., Miller, W. M., McMillan, K. P., Brown, T. J., Sanders, V. M., & Jones, K. J. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23814 · Cited by 5
Increased IL-17, a Pathogenic Link between Hepatosplenic Schistosomiasis and Amyotrophic Lateral Sclerosis: A Hypothesis
Moling, O., Summa, A. D., Capone, L., Stuefer, J., Piccin, A., Porzia, A., Capozzi, A., Sorice, M., Binazzi, R., Gandini, L., et al. (2014) · Case Reports in Immunology · doi:10.1155/2014/804761 · Cited by 5
Effects of Dietary Components on Microglia Inactivation in Alzheimer’s Disease
Bhatia, H. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811959-4.00008-0 · Cited by 5
Blood Level of Glial Fibrillary Acidic Protein (GFAP) Does not Correlate With Disease Progression in a Rat Model of Familial ALS (SOD1G93A Transgenic)
Jeffrey, J. I., D’Cunha, H., & Suzuki, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00954 · Cited by 5
Coexistence of amyotrophic lateral sclerosis with neuro‐ B ehçet's disease presenting as a longitudinally extensive spinal cord lesion: clinicopathologic features of an autopsied patient
Sato, T., Ouchi, H., Shimbo, J., Sato, A., Yamazaki, M., Hashidate, H., Igarashi, S., & Kakita, A. (2013) · Neuropathology · doi:10.1111/neup.12074 · Cited by 5
Role of 2-[18F]FDG-PET as a biomarker of upper motor neuron involvement in amyotrophic lateral sclerosis
Cabras, S., Manera, U., Pede, F. D., Zocco, G., Vasta, R., Novara, A., Minerva, E., Matteoni, E., Mattei, F. D., Pellegrino, G., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13501-6 · Cited by 4
Oral Treatment with RD2RD2 Impedes Development of Motoric Phenotype and Delays Symptom Onset in SOD1G93A Transgenic Mice
Post, J., Schaffrath, A., Gering, I., Hartwig, S., Lehr, S., Shah, N. J., Langen, K., Willbold, D., Kutzsche, J., & Willuweit, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137066 · Cited by 4
The role of glial cells in amyotrophic lateral sclerosis
Pandya, V. A., & Patani, R. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.005 · Cited by 5
Rutin Ameliorates ALS Pathology by Reducing SOD1 Aggregation and Neuroinflammation in an SOD1-G93A Mouse Model
Du, X., Dong, Q.-X., Zhu, J., Li, L., Yu, X., & Liu, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910392 · Cited by 4
The Neuroinflammation in the Physiopathology of Amyotrophic Lateral Sclerosis
Bowerman, M., Vincent, T., Scamps, F., Camu, W., & Raoul, C. (2013) · InTech eBooks · doi:10.5772/56489 · Cited by 5
Far beyond the motor neuron: the role of glial cells in amyotrophic lateral sclerosis
de Souza, P. V. S., Pinto, W. B. V. D. R., Filho, F. M. R., & Oliveira, A. S. B. (2016) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20160117 · Cited by 4
Metals and Autophagy in Neurotoxicity
Su, P., Aschner, M., Chen, J., & Luo, W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00019-1 · Cited by 4
Animal Models and Experimental Research in Medicine
Karapehlivan, M., Gelen, V., & Kükürt, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100993 · Cited by 4

Authors: Philips, T., & Robberecht, W.
Affiliations: KU Leuven (BE)
Corresponding author: Robberecht, Wim
ORCID: Philips, Thomas
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2011-03
Volume: 10
Issue: 3
Pages: 253-263
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(11)70015-1
OpenAlex: W2144507462
Cited by: 646
References: 133
Citations by year: 2026: 25 · 2025: 24 · 2024: 39 · 2023: 45 · 2022: 38 · 2021: 44 · 2020: 45 · 2019: 41 · 2018: 43 · 2017: 58 · 2016: 44 · 2015: 41 · 2014: 52 · 2013: 53 · 2012: 40
FWCI: 6.36
Type: journal article
Language: en
Open access: green
zenodo.org
Licence: other-oa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
Keywords: amyotrophic lateral sclerosis, neuroinflammation, glial activation, microglia, astrocytes, motor neuron degeneration, neurodegeneration
MeSH terms: Amyotrophic Lateral Sclerosis, Animals, Humans, Inflammation, Neuroglia, T-Lymphocytes, Signal Transduction, Motor Neuron Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks